P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Current Portion of Long-Term Debt
â‚©33.7B
CAGR 3-Years
93%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Current Portion of Long-Term Debt
â‚©175.7B
CAGR 3-Years
36%
CAGR 5-Years
15%
CAGR 10-Years
-2%
SK Bioscience Co Ltd
KRX:302440
Current Portion of Long-Term Debt
â‚©8.1B
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Current Portion of Long-Term Debt
â‚©31B
CAGR 3-Years
-38%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Current Portion of Long-Term Debt
â‚©2.7B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Current Portion of Long-Term Debt
â‚©88.9B
CAGR 3-Years
11%
CAGR 5-Years
295%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P

See Also

What is PharmaResearch Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
33.7B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Current Portion of Long-Term Debt amounts to 33.7B KRW.

What is PharmaResearch Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
61%

Over the last year, the Current Portion of Long-Term Debt growth was 954%. The average annual Current Portion of Long-Term Debt growth rates for PharmaResearch Co Ltd have been 93% over the past three years , 61% over the past five years .

Back to Top